Echo IQ Limited

Company Profile

Sector

Healthcare

Industry

Health Information Services

Employees

N/A

Website

www.echoiq.ai

Country

Australia

Exchange

ASX

Sydney, Australia

Echo IQ provides artificial intelligence (AI) diagnostics tool that enhance the diagnosis of structural heart disease in Australia. It offers EchoSolv, provides an AI-powered risk assessment of structural heart disease, including aortic stenosis, diastolic dysfunction, and heart failure. The company has a research collaboration with Mayo Clinic to evaluate echo IQ's proprietary artificial intelligence platform for cardiac risk stratification in oncology patients. Formerly known as Houston We Have Limited, the company rebranded as EchoIQ Limited in December 2021. Echo IQ Limited is headquartered in Sydney, Australia.

Key Stats

52-Week Range

A$0.17A$1.88

Beta0.18

Trailing P/EN/A

Forward P/E-89.32

Trailing EPS-0.03

Avg Volume

Earnings & Analyst

Next EarningsN/A

EPS EstimateN/A

Target Mean PriceA$1.90

RecommendationStrong Buy

Recommendation Mean1.50

Recent SEC Filings

SEC filings for this ticker are not available yet.